Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v7-EN | Version v1-EN | |
---|---|---|
Language | English | English |
Date Updated | 2018-12-20 | 2018-12-14 |
Drug Identification Number | 02241676 | 02241676 |
Brand name | POTASSIUM CHLORIDE INJECTION | POTASSIUM CHLORIDE INJECTION |
Common or Proper name | POTASSIUM CHLORIDE 10MMOL IN 100ML SWI 30EA/CA | POTASSIUM CHLORIDE 10MMOL IN 100ML SWI 30EA/CA |
Company Name | BAXTER CORPORATION | BAXTER CORPORATION |
Ingredients | POTASSIUM CHLORIDE | POTASSIUM CHLORIDE |
Strength(s) | 7.46MG | 7.46MG |
Dosage form(s) | LIQUID | LIQUID |
Route of administration | INTRAVENOUS | INTRAVENOUS |
Packaging size | 100 mL | 100 mL |
ATC code | B05XA | B05XA |
ATC description | I.V. SOLUTION ADDITIVES | I.V. SOLUTION ADDITIVES |
Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
Anticipated start date | 2018-12-14 | 2018-12-14 |
Actual start date | 2018-12-14 | 2018-12-14 |
Estimated end date | 2018-12-19 | 2018-12-19 |
Actual end date | 2018-12-19 | |
Shortage status | Resolved | Anticipated shortage |
Tier 3 Status | No | No |
Company comments | Temporary stockout due to large order. For questions or concerns contact Baxter customer care (1.888.719.9955) or your local representative. | Temporary stockout due to large order For questions or concerns contact Baxter customer care (1.888.719.9955) or your local representative. |
Health Canada comments |